CMPX Stock-Based Compensation
Compass Therapeutics · Stock-Based Compensation
CMPX Stock-Based Compensation
Latest reported$12.96Mperiod ending
CMPX Stock-Based Comp ($656.00K → $12.96M)
Annual stock-based compensation
High-resolution chart · PNG
CMPX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,368,000 | |
| 8,560,000 | |
| 6,120,000 | |
| 5,330,000 | |
| 4,029,000 | |
| 4,016,000 | |
| 915,000 | |
| 656,000 |